Korro Bio (KRRO) Operating Leases (2020 - 2026)
Korro Bio's (KRRO) quarterly Operating Leases came in at $42.9 million in Q1 2026, little changed YoY from $42.9 million in Q1 2025, and up 5.07% on a QoQ basis from $40.8 million in Q4 2025.
Korro Bio (KRRO) Operating Leases (2020 - 2026) Analysis & Trends
Korro Bio (KRRO) has 7 years of Operating Leases data on file, last reported at $42.9 million in Q1 2026.
- Quarterly Operating Leases changed 0.01% year-over-year to $42.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.9 million (changed 0.01% YoY) and the FY2025 annual result came in at $40.8 million, down 6.13% from the prior year.
- Operating Leases grew to $42.9 million in Q1 2026, from $40.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $44.6 million in Q2 2025 to a low of $209000.0 in Q4 2022.
- A 5-year average of $33.6 million and a median of $36.3 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases sank 99.28% — and 2023, when it soared 14835.89%.
- Tracing KRRO's Operating Leases over 5 years: stood at $209000.0 in 2022, then soared by 14835.89% to $31.2 million in 2023, then surged by 39.29% to $43.5 million in 2024, then dropped by 6.13% to $40.8 million in 2025, then increased by 5.07% to $42.9 million in 2026.
- The last three Operating Leases figures came in at $42.9 million (Q1 2026), $40.8 million (Q4 2025), and $41.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Korro Bio | 228.60 Mn | 113.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.21 Mn |
| Mar 31, 2026 | 42.89 Mn |
| Dec 31, 2025 | 40.81 Mn |
| Sep 30, 2025 | 41.52 Mn |
| Jun 30, 2025 | 44.63 Mn |
| Mar 31, 2025 | 42.88 Mn |
| Dec 31, 2024 | 43.48 Mn |
| Sep 30, 2024 | 41.79 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 34.68 Mn |
| Dec 31, 2023 | 31.22 Mn |
| Jun 30, 2023 | 25.65 Mn |
| Mar 31, 2023 | 26.22 Mn |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 27.29 Mn |
| Jun 30, 2022 | 27.81 Mn |
| Mar 31, 2022 | 28.37 Mn |
| Dec 31, 2021 | 28.85 Mn |
| Sep 30, 2021 | 29.31 Mn |
| Jun 30, 2021 | 29.75 Mn |